gennova-biopharmaceuticals-limitedgennova-biopharmaceuticals-limited
  • Home
    • Home
    • Contact Us
    • Careers
  • About Us
    • About Us
    • Company Profile
    • Our Values
    • Board of Directors
    • Our Strengths
    • PDL
    • Our Collaborations
  • Media
    • Media
    • News Coverage
    • Gallery
    • Employee Moments
  • Products
    • Products
    • Elaxim®
    • GEMCOVAC®-OM
    • Hamsyl®
    • Hamsyl® Junior
    • PEGEX®
    • Vintor®
    • Xgrast®
  • Publications
  • Abhyudaya
  • Transforming Healthcare
    • Transforming Healthcare
    • Global Health Initiative
      • Global Health Initiative
      • PHT
Gennova Logo Gennova Logo
  • Home
    • Home
    • Contact Us
    • Careers
  • About Us
    • About Us
    • Company Profile
    • Our Values
    • Board of Directors
    • Our Strengths
    • PDL
    • Our Collaborations
  • Media
    • Media
    • News Coverage
    • Gallery
    • Employee Moments
  • Products
    • Products
    • Elaxim®
    • GEMCOVAC®-OM
    • Hamsyl®
    • Hamsyl® Junior
    • PEGEX®
    • Vintor®
    • Xgrast®
  • Publications
  • Abhyudaya
  • Transforming Healthcare
    • Transforming Healthcare
    • Global Health Initiative
      • Global Health Initiative
      • PHT

Blogs

Home Page
 
  • Research Articles

    Activation of HRI is mediated by Hsp90 during stress through modulation of the HRI-Hsp90 complex.

    By admin/April 9, 2020
    Int J Biol Macromol. 2018 Oct 15;118(Pt B):1604-1613. doi: 10.1016/j.ijbiomac.2018.06.204. Epub 2018 Jul 3. PubMed PMID: 30170366. https://www.ncbi.nlm.nih.gov/pubmed/?term=30170366
    Read More
    Share
  • Research Articles

    The Leishmania donovani IMPACT-like protein possesses non-specific nuclease activity.

    By admin/April 9, 2020
    Int J Biol Macromol. 2018 Nov;119:962-973. doi: 10.1016/j.ijbiomac.2018.07.175 https://www.ncbi.nlm.nih.gov/pubmed/30077668
    Read More
    Share
  • Research Articles

    Malaria vaccine candidate based on Duffy-binding protein elicits strain transcending functional antibodies in a Phase I trial.

    By admin/April 9, 2020
    NPJ Vaccines. 2018 Sep 28;3:48. doi: 10.1038/s41541-018-0083-3. eCollection 2018. PubMed PMID: 30302285; PubMed Central PMCID: PMC6162314. https://www.ncbi.nlm.nih.gov/pubmed/?term=30302285
    Read More
    Share
  • Research Articles

    The Plasmodium falciparum circumsporozoite protein produced in Lactococcus lactis is pure and stable.

    By admin/April 9, 2020
    J Biol Chem. 2020 Jan 10;295(2):403-414. doi: 10.1074/jbc.RA119.011268. https://www.ncbi.nlm.nih.gov/pubmed/31792057
    Read More
    Share
  • Patents

    A novel purification process for isolation and commercial production of recombinant tnk-tpa tenecteplase

    By admin/April 9, 2020
    US20180223270A1 https://patents.google.com/patent/US20180223270A1
    Read More
    Share
  • Patents

    A novel process for purification of rhu-gcsf

    By admin/April 9, 2020
    US20170210784A1 https://patents.google.com/patent/US20170210784A1
    Read More
    Share
  • Patents

    Pharmaceutical compositions of tenecteplase

    By admin/April 9, 2020
    US9943575B2 https://patents.google.com/patent/US9943575B2
    Read More
    Share
previous page 1 2 3
Gennova Logo

About Gennova

Board of Directors
Research Collaborations
Corporate Governance
Form 5A
Internships
Careers
Press Kit
Contact Us

Products

Elaxim®
GEMCOVAC®-OM
Hamsyl®
Hamsyl® Junior

PEGEX®
TENECTASE®
Vintor®
Xgrast®

PRIVACY POLICY | TERMS OF USE | DISCLAIMER | COOKIE POLICY

©2006-2025 Gennova Biopharmaceuticals Limited. All rights reserved.